DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience

Basit Öğe Kaydı
dc.authoridKAYA, Emin/0000-0001-8605-8497
dc.authoridGozukara Bag, Harika Gozde/0000-0003-1208-4072
dc.authoridBERBER, Ilhami/0000-0003-3312-8476
dc.authoridErkurt, Mehmet Ali/0000-0002-3285-417X
dc.authorwosidKAYA, Emin/W-2951-2017
dc.authorwosidGozukara Bag, Harika Gozde/ABG-7588-2020
dc.authorwosidBERBER, Ilhami/ABI-6231-2020
dc.authorwosidErkurt, Mehmet Ali/ABI-7232-2020
dc.contributor.authorBerber, Ilhami
dc.contributor.authorErkurt, Mehmet Ali
dc.contributor.authorKuku, Irfan
dc.contributor.authorMaya, Emin
dc.contributor.authorBag, Harika Gozukara
dc.contributor.authorNizam, Ilknur
dc.contributor.authorKoroglu, Mustafa
dc.date.accessioned2024-08-04T20:41:27Z
dc.date.available2024-08-04T20:41:27Z
dc.date.issued2016
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThis study aimed to evaluate the efficiency of DHAP regimen plus filgrastim for mobilization of stem cells in patients with recurrent and/or refractory lymphoma. Thirty-four patients who took DHAP as salvage therapy prior to autologous stem cell transplantation were included. After chemotherapies, 2 cycles of DHAP plus filgrastim were administered to the patients. Stem cells from 32 patients (94%) were collected on median 11th day (8-12), and the median collected CD34(+) cell dose was 9.7 x 10(6)/kg (range 3.8-41.6). DHAP plus filgrastim was found to be an effective chemotherapy regimen in mobilizing CD34(+) stem cells into the peripheral. (c) 2016 Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/j.transci.2016.01.012
dc.identifier.endpage52en_US
dc.identifier.issn1473-0502
dc.identifier.issue1en_US
dc.identifier.pmid26809684en_US
dc.identifier.scopus2-s2.0-84955315160en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage48en_US
dc.identifier.urihttps://doi.org/10.1016/j.transci.2016.01.012
dc.identifier.urihttps://hdl.handle.net/11616/97138
dc.identifier.volume54en_US
dc.identifier.wosWOS:000374614700009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.ispartofTransfusion and Apheresis Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDHAP plus filgrastimen_US
dc.subjectStem cell mobilizationen_US
dc.subjectLymphomaen_US
dc.titleDHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experienceen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu